An Investigation of Light Therapy for Cancer-related Fatigue (The LITE Study)
NCT ID: NCT01780623
Last Updated: 2016-04-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
88 participants
INTERVENTIONAL
2013-01-31
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treating Cancer-Related Fatigue Through Systematic Light Exposure
NCT01873794
Effect on Fatigue of Light (Lux) Therapy in Patients With Cancer
NCT02879864
Light Therapy to Increase Energy in Adolescents and Young Adults Newly Diagnosed With Solid Tumors: A Pilot Study
NCT02429063
Pilot Comparison of N-of-1 Trials of Light Therapy
NCT03167372
The Effects of Light Therapy to Treat Cancer-related Side Effects
NCT04418856
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bright White Light
Bright white light exposure every morning for 30 minutes for 28 consecutive days
Bright white light
Dim Red Light
Dim red light exposure every morning for 30 minutes for 28 consecutive days
Dim red light
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bright white light
Dim red light
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non metastatic cancer
* At least 3 months post chemotherapy/radiation treatment (hormone treatment ok)
* Meets criteria for cancer-related fatigue
Exclusion Criteria
* Presence of a sleep disorder other than insomnia or hypersomnia
* Shift work
* Presence of an Axis-I psychiatric condition
* Presence of a medical condition that may impact levels of fatigue
* Presence of conditions contraindicated to the use of light therapy or photosensitizing medications
* Randomization refusal
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Canadian Cancer Society (CCS)
OTHER
University of Calgary
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tavis S. Campbell
Dr. Tavis S. Campbell
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tavis S Campbell, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Calgary
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Behavioural Medicine Laboratory
Calgary, Alberta, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Johnson JA, Subnis U, Carlson LE, Garland SN, Santos-Iglesias P, Piedalue KL, Deleemans JM, Campbell TS. Effects of a light therapy intervention on diurnal salivary cortisol in fatigued cancer survivors: A secondary analysis of a randomized controlled trial. J Psychosom Res. 2020 Dec;139:110266. doi: 10.1016/j.jpsychores.2020.110266. Epub 2020 Oct 6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10003569
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.